Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.
Identifieur interne : 000039 ( Main/Exploration ); précédent : 000038; suivant : 000040Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.
Auteurs : Kavita K. Mishra [États-Unis] ; Armin Afshar [États-Unis] ; Juliette Thariat [France] ; Helen A. Shih [États-Unis] ; Jessica E. Scholey [États-Unis] ; Inder K. Daftari [États-Unis] ; Andrzej Kacperek [Royaume-Uni] ; Alessia Pica [Suisse] ; Jan Hrbacek [Suisse] ; Remi Dendale [France] ; Alejandro Mazal [Espagne] ; Jens Heufelder [Allemagne] ; Devron H. Char [États-Unis] ; Wolfgang A G. Sauerwein [Allemagne] ; Damien C. Weber [Suisse] ; Bertil E. Damato [Royaume-Uni]Source :
- Advances in radiation oncology [ 2452-1094 ]
Abstract
Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the coronavirus disease (COVID-19) pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group is the largest international community of particle/proton therapy providers. Participating experts have current or former affiliation with the member institutions of the Particle Therapy Co-Operative Group Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of health care providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears, and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.
DOI: 10.1016/j.adro.2020.04.010
PubMed: 32337386
PubMed Central: PMC7179507
Affiliations:
- Allemagne, Espagne, France, Royaume-Uni, Suisse, États-Unis
- Angleterre, Basse-Normandie, Berlin, Californie, Communauté de Madrid, Massachusetts, Oxfordshire, Région Normandie
- Berlin, Caen, Madrid, Orsay, Oxford
- Université d'Oxford
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.</title><author><name sortKey="Mishra, Kavita K" sort="Mishra, Kavita K" uniqKey="Mishra K" first="Kavita K" last="Mishra">Kavita K. Mishra</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Afshar, Armin" sort="Afshar, Armin" uniqKey="Afshar A" first="Armin" last="Afshar">Armin Afshar</name><affiliation wicri:level="2"><nlm:affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Ophthalmology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Thariat, Juliette" sort="Thariat, Juliette" uniqKey="Thariat J" first="Juliette" last="Thariat">Juliette Thariat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Centre François Baclesse, Normandie Universite, Caen, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Radiation Oncology, Centre François Baclesse, Normandie Universite, Caen</wicri:regionArea><placeName><region type="region">Région Normandie</region><region type="old region">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Shih, Helen A" sort="Shih, Helen A" uniqKey="Shih H" first="Helen A" last="Shih">Helen A. Shih</name><affiliation wicri:level="2"><nlm:affiliation>F.H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>F.H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Scholey, Jessica E" sort="Scholey, Jessica E" uniqKey="Scholey J" first="Jessica E" last="Scholey">Jessica E. Scholey</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Daftari, Inder K" sort="Daftari, Inder K" uniqKey="Daftari I" first="Inder K" last="Daftari">Inder K. Daftari</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Kacperek, Andrzej" sort="Kacperek, Andrzej" uniqKey="Kacperek A" first="Andrzej" last="Kacperek">Andrzej Kacperek</name><affiliation wicri:level="1"><nlm:affiliation>National Proton Therapy Centre, Clatterbridge Cancer Centre, Wirral, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Proton Therapy Centre, Clatterbridge Cancer Centre, Wirral</wicri:regionArea><wicri:noRegion>Wirral</wicri:noRegion></affiliation></author><author><name sortKey="Pica, Alessia" sort="Pica, Alessia" uniqKey="Pica A" first="Alessia" last="Pica">Alessia Pica</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Hrbacek, Jan" sort="Hrbacek, Jan" uniqKey="Hrbacek J" first="Jan" last="Hrbacek">Jan Hrbacek</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name><affiliation wicri:level="3"><nlm:affiliation>Institut Curie Proton Therapy Center, Orsay, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Curie Proton Therapy Center, Orsay</wicri:regionArea><placeName><settlement type="city">Orsay</settlement></placeName></affiliation></author><author><name sortKey="Mazal, Alejandro" sort="Mazal, Alejandro" uniqKey="Mazal A" first="Alejandro" last="Mazal">Alejandro Mazal</name><affiliation wicri:level="3"><nlm:affiliation>Centro de Protonterapia Quironsalud, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Protonterapia Quironsalud, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Heufelder, Jens" sort="Heufelder, Jens" uniqKey="Heufelder J" first="Jens" last="Heufelder">Jens Heufelder</name><affiliation wicri:level="3"><nlm:affiliation>BerlinProtonen am HZB, Charité-Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>BerlinProtonen am HZB, Charité-Universitätsmedizin Berlin, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Char, Devron H" sort="Char, Devron H" uniqKey="Char D" first="Devron H" last="Char">Devron H. Char</name><affiliation wicri:level="2"><nlm:affiliation>The Tumori Foundation, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>The Tumori Foundation, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Sauerwein, Wolfgang A G" sort="Sauerwein, Wolfgang A G" uniqKey="Sauerwein W" first="Wolfgang A G" last="Sauerwein">Wolfgang A G. Sauerwein</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, University Hospital Essen, Essen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University Hospital Essen, Essen</wicri:regionArea><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion></affiliation></author><author><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Damato, Bertil E" sort="Damato, Bertil E" uniqKey="Damato B" first="Bertil E" last="Damato">Bertil E. Damato</name><affiliation wicri:level="4"><nlm:affiliation>Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jul-Aug</date><idno type="RBID">pubmed:32337386</idno><idno type="pmid">32337386</idno><idno type="doi">10.1016/j.adro.2020.04.010</idno><idno type="pmc">PMC7179507</idno><idno type="wicri:Area/Main/Corpus">001578</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001578</idno><idno type="wicri:Area/Main/Curation">001578</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001578</idno><idno type="wicri:Area/Main/Exploration">001578</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.</title><author><name sortKey="Mishra, Kavita K" sort="Mishra, Kavita K" uniqKey="Mishra K" first="Kavita K" last="Mishra">Kavita K. Mishra</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Afshar, Armin" sort="Afshar, Armin" uniqKey="Afshar A" first="Armin" last="Afshar">Armin Afshar</name><affiliation wicri:level="2"><nlm:affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Ophthalmology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Thariat, Juliette" sort="Thariat, Juliette" uniqKey="Thariat J" first="Juliette" last="Thariat">Juliette Thariat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Centre François Baclesse, Normandie Universite, Caen, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Radiation Oncology, Centre François Baclesse, Normandie Universite, Caen</wicri:regionArea><placeName><region type="region">Région Normandie</region><region type="old region">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Shih, Helen A" sort="Shih, Helen A" uniqKey="Shih H" first="Helen A" last="Shih">Helen A. Shih</name><affiliation wicri:level="2"><nlm:affiliation>F.H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>F.H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Scholey, Jessica E" sort="Scholey, Jessica E" uniqKey="Scholey J" first="Jessica E" last="Scholey">Jessica E. Scholey</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Daftari, Inder K" sort="Daftari, Inder K" uniqKey="Daftari I" first="Inder K" last="Daftari">Inder K. Daftari</name><affiliation wicri:level="2"><nlm:affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Kacperek, Andrzej" sort="Kacperek, Andrzej" uniqKey="Kacperek A" first="Andrzej" last="Kacperek">Andrzej Kacperek</name><affiliation wicri:level="1"><nlm:affiliation>National Proton Therapy Centre, Clatterbridge Cancer Centre, Wirral, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>National Proton Therapy Centre, Clatterbridge Cancer Centre, Wirral</wicri:regionArea><wicri:noRegion>Wirral</wicri:noRegion></affiliation></author><author><name sortKey="Pica, Alessia" sort="Pica, Alessia" uniqKey="Pica A" first="Alessia" last="Pica">Alessia Pica</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Hrbacek, Jan" sort="Hrbacek, Jan" uniqKey="Hrbacek J" first="Jan" last="Hrbacek">Jan Hrbacek</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name><affiliation wicri:level="3"><nlm:affiliation>Institut Curie Proton Therapy Center, Orsay, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Curie Proton Therapy Center, Orsay</wicri:regionArea><placeName><settlement type="city">Orsay</settlement></placeName></affiliation></author><author><name sortKey="Mazal, Alejandro" sort="Mazal, Alejandro" uniqKey="Mazal A" first="Alejandro" last="Mazal">Alejandro Mazal</name><affiliation wicri:level="3"><nlm:affiliation>Centro de Protonterapia Quironsalud, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Protonterapia Quironsalud, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Heufelder, Jens" sort="Heufelder, Jens" uniqKey="Heufelder J" first="Jens" last="Heufelder">Jens Heufelder</name><affiliation wicri:level="3"><nlm:affiliation>BerlinProtonen am HZB, Charité-Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>BerlinProtonen am HZB, Charité-Universitätsmedizin Berlin, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Char, Devron H" sort="Char, Devron H" uniqKey="Char D" first="Devron H" last="Char">Devron H. Char</name><affiliation wicri:level="2"><nlm:affiliation>The Tumori Foundation, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>The Tumori Foundation, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Sauerwein, Wolfgang A G" sort="Sauerwein, Wolfgang A G" uniqKey="Sauerwein W" first="Wolfgang A G" last="Sauerwein">Wolfgang A G. Sauerwein</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, University Hospital Essen, Essen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University Hospital Essen, Essen</wicri:regionArea><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion></affiliation></author><author><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name><affiliation wicri:level="1"><nlm:affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Center for Proton Therapy, Paul Scherrer Institute, Villigen</wicri:regionArea><wicri:noRegion>Villigen</wicri:noRegion></affiliation></author><author><name sortKey="Damato, Bertil E" sort="Damato, Bertil E" uniqKey="Damato B" first="Bertil E" last="Damato">Bertil E. Damato</name><affiliation wicri:level="4"><nlm:affiliation>Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author></analytic><series><title level="j">Advances in radiation oncology</title><idno type="ISSN">2452-1094</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the coronavirus disease (COVID-19) pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group is the largest international community of particle/proton therapy providers. Participating experts have current or former affiliation with the member institutions of the Particle Therapy Co-Operative Group Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of health care providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears, and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32337386</PMID><DateRevised><Year>2020</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2452-1094</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>4</Issue><PubDate><MedlineDate>2020 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Advances in radiation oncology</Title><ISOAbbreviation>Adv Radiat Oncol</ISOAbbreviation></Journal><ArticleTitle>Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.</ArticleTitle><Pagination><MedlinePgn>682-686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.adro.2020.04.010</ELocationID><Abstract><AbstractText>Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the coronavirus disease (COVID-19) pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group is the largest international community of particle/proton therapy providers. Participating experts have current or former affiliation with the member institutions of the Particle Therapy Co-Operative Group Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of health care providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears, and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.</AbstractText><CopyrightInformation>© 2020 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Kavita K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshar</LastName><ForeName>Armin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thariat</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Centre François Baclesse, Normandie Universite, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Helen A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>F.H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scholey</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daftari</LastName><ForeName>Inder K</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Ocular Tumor Proton Therapy Program, Department of Radiation Oncology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kacperek</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Proton Therapy Centre, Clatterbridge Cancer Centre, Wirral, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pica</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hrbacek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dendale</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institut Curie Proton Therapy Center, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazal</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Protonterapia Quironsalud, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heufelder</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BerlinProtonen am HZB, Charité-Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Char</LastName><ForeName>Devron H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>The Tumori Foundation, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauerwein</LastName><ForeName>Wolfgang A G</ForeName><Initials>WAG</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Damien C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damato</LastName><ForeName>Bertil E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Radiat Oncol</MedlineTA><NlmUniqueID>101677247</NlmUniqueID><ISSNLinking>2452-1094</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32337386</ArticleId><ArticleId IdType="doi">10.1016/j.adro.2020.04.010</ArticleId><ArticleId IdType="pii">S2452-1094(20)30085-3</ArticleId><ArticleId IdType="pmc">PMC7179507</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Espagne</li><li>France</li><li>Royaume-Uni</li><li>Suisse</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Basse-Normandie</li><li>Berlin</li><li>Californie</li><li>Communauté de Madrid</li><li>Massachusetts</li><li>Oxfordshire</li><li>Région Normandie</li></region><settlement><li>Berlin</li><li>Caen</li><li>Madrid</li><li>Orsay</li><li>Oxford</li></settlement><orgName><li>Université d'Oxford</li></orgName></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Mishra, Kavita K" sort="Mishra, Kavita K" uniqKey="Mishra K" first="Kavita K" last="Mishra">Kavita K. Mishra</name></region><name sortKey="Afshar, Armin" sort="Afshar, Armin" uniqKey="Afshar A" first="Armin" last="Afshar">Armin Afshar</name><name sortKey="Char, Devron H" sort="Char, Devron H" uniqKey="Char D" first="Devron H" last="Char">Devron H. Char</name><name sortKey="Daftari, Inder K" sort="Daftari, Inder K" uniqKey="Daftari I" first="Inder K" last="Daftari">Inder K. Daftari</name><name sortKey="Scholey, Jessica E" sort="Scholey, Jessica E" uniqKey="Scholey J" first="Jessica E" last="Scholey">Jessica E. Scholey</name><name sortKey="Shih, Helen A" sort="Shih, Helen A" uniqKey="Shih H" first="Helen A" last="Shih">Helen A. Shih</name></country><country name="France"><region name="Région Normandie"><name sortKey="Thariat, Juliette" sort="Thariat, Juliette" uniqKey="Thariat J" first="Juliette" last="Thariat">Juliette Thariat</name></region><name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Kacperek, Andrzej" sort="Kacperek, Andrzej" uniqKey="Kacperek A" first="Andrzej" last="Kacperek">Andrzej Kacperek</name></noRegion><name sortKey="Damato, Bertil E" sort="Damato, Bertil E" uniqKey="Damato B" first="Bertil E" last="Damato">Bertil E. Damato</name></country><country name="Suisse"><noRegion><name sortKey="Pica, Alessia" sort="Pica, Alessia" uniqKey="Pica A" first="Alessia" last="Pica">Alessia Pica</name></noRegion><name sortKey="Hrbacek, Jan" sort="Hrbacek, Jan" uniqKey="Hrbacek J" first="Jan" last="Hrbacek">Jan Hrbacek</name><name sortKey="Weber, Damien C" sort="Weber, Damien C" uniqKey="Weber D" first="Damien C" last="Weber">Damien C. Weber</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Mazal, Alejandro" sort="Mazal, Alejandro" uniqKey="Mazal A" first="Alejandro" last="Mazal">Alejandro Mazal</name></region></country><country name="Allemagne"><region name="Berlin"><name sortKey="Heufelder, Jens" sort="Heufelder, Jens" uniqKey="Heufelder J" first="Jens" last="Heufelder">Jens Heufelder</name></region><name sortKey="Sauerwein, Wolfgang A G" sort="Sauerwein, Wolfgang A G" uniqKey="Sauerwein W" first="Wolfgang A G" last="Sauerwein">Wolfgang A G. Sauerwein</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000039 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000039 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32337386
|texte= Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32337386" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |